Iovance Biotherapeutics, Inc. short interest in 2023
In 2023, Iovance Biotherapeutics, Inc.'s disclosed short interest ran from 12.74% of shares outstanding on 13 Jan 2023 to 14.23% on 29 Dec 2023, a change of +1.49 percentage points. The year's high was 15.88% on 31 Mar 2023 and its low 9.65% on 31 May 2023, averaging 13.15% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.15 days on 28 Apr 2023. Full history: Iovance Biotherapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 12.74% (13 Jan 2023)
- End of year
- 14.23% (29 Dec 2023)
- Change
- +1.49 pp
- High
- 15.88% (31 Mar 2023)
- Low
- 9.65% (31 May 2023)
- Average
- 13.15%
- Highest days to cover
- 9.15 (28 Apr 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 12.74% | 6.33 | |
| 31 Jan 2023 | 13.11% | 3.02 | |
| 15 Feb 2023 | 12.55% | 6.07 | |
| 28 Feb 2023 | 12.25% | 6.31 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 14.32% | 6.40 | |
| 31 Mar 2023 | 15.88% | 6.12 | |
| 14 Apr 2023 | 14.71% | 6.70 | |
| 28 Apr 2023 | 15.13% | 9.15 | |
| 15 May 2023 | 10.42% | 4.66 | results (8-K), 10-Q filed |
| 31 May 2023 | 9.65% | 2.53 | |
| 15 Jun 2023 | 11.42% | 4.38 | |
| 30 Jun 2023 | 12.87% | 5.14 | |
| 14 Jul 2023 | 11.57% | 3.48 | results (8-K) |
| 31 Jul 2023 | 12.27% | 6.83 | |
| 15 Aug 2023 | 11.11% | 5.91 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 12.14% | 7.98 | |
| 15 Sep 2023 | 12.31% | 2.99 | |
| 29 Sep 2023 | 14.84% | 4.57 | |
| 13 Oct 2023 | 15.64% | 7.40 | |
| 31 Oct 2023 | 15.19% | 7.01 | |
| 15 Nov 2023 | 13.91% | 5.79 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 13.52% | 4.14 | |
| 15 Dec 2023 | 13.78% | 4.60 | |
| 29 Dec 2023 | 14.23% | 3.19 |
See also: Iovance Biotherapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.